# Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

> **NCT05334784** · NA · ENROLLING_BY_INVITATION · sponsor: **Abiomed Inc.** · enrollment: 856 (estimated)

## Conditions studied

- High-Risk Percutaneous Coronary Intervention

## Interventions

- **DEVICE:** Impella ECP

## Key facts

- **NCT ID:** NCT05334784
- **Lead sponsor:** Abiomed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-12-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 856 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05334784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05334784, "Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05334784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*